|
Corthera Closes a $23 Million Financing Round
In this series C funding, new investor Caxton Advantage Life Sciences Fund, a fund focused on development-stage public and private companies in the life sciences field, joined existing top-tier investors Domain Associates and Kleiner, Perkins, Caufield & Byers in the financing round. (read full story at: pharmalive.com)
|
|
Comments